1 Since then many terms were employed to describe cases of pancreatitis with similar characteristics until 1995 when, for the first time, the term autoimmune pancreatitis (AIP) was applied.2 From this date, many advances in the understanding of this entity have been recorded. At the same SB431542 research buy time, an increased incidence of pancreatic diseases in patients with inflammatory bowel disease (IBD) has been reported, namely with ulcerative colitis (UC). This may be drug-related or due to the increased incidence of cholelithiasis among IBD patients.3 However rarer forms of chronic pancreatitis

are described, and its association with AIP is underlined by different case reports, although the true incidence is still unknown.3, 4 and 5 We present the case of a 34-year-old white man with no past medical history who developed malaise, fatigue, persistent epigastric discomfort and one month later jaundice. There was no history of alcohol intake, drug abuse or medication. The physical exam was unremarkable except for jaundice and epigastric pain. Laboratory evaluation was remarkable for abnormal liver function tests with cholestasis and slight hepatic cytolysis (alkaline phosphatase, 340 UI/L; gamma-glutamyl high throughput screening compounds transferase, 191 UI/L; total bilirubin, 5.57 mg/dl; aspartate aminotransferase, 86 UI/L;

oxyclozanide alanine aminotransferase, 102 UI/L). Abdominal ultrasound was consistent with extra-hepatic cholestasis and an abdominal computed tomography (CT) documented common bile duct (CBD) narrowing at the pancreatic level, which was described as normal. The endoscopic retrograde cholangiopancreatography (ERCP) confirmed the intra-pancreatic regular CBD stenosis without further changes of the extra-pancreatic bile structures (Fig. 1A). Biliary citology was

negative for malignancy. Pancreatic duct canulation was unsuccessful and a 10 Fr biliary stent was placed (Fig. 1B). For further evaluation a magnetic resonance imaging-cholangiopancreatography (MRI-CP) was ordered, which revealed discrete pancreatic head heterogeneity, with no main pancreatic duct (MPD) abnormalities. An endoscopic ultrasound (EUS) showed an abnormal pancreatic head, overall hypoechoic, heterogeneity and slightly increased, with no MPD visualization (Fig. 2). This was felt suggestive of AIP and fine needle aspiration with a 19 g Trucut needle (Cook) at the pancreatic neck was performed. Histology showed extensive pancreatic fibrosis, marked ductopenia, diffuse lymphocytic infiltration predominantly periductal as well as peri-venular lymphocytic infiltrates (Fig. 3). These findings were felt to support the diagnosis of AIP. Additional laboratory evaluation showed increase of IgG4 (212 mg/dl).